Memory Enriched Epstein-Barr Virus {EBV} Specific T-Cells with Broader Target Antigen Repertoire for the Treatment of EBV plus Malignancies

被引：0
|
作者：
Sharma, Sandhya [1 ,2 ]
Mehta, Naren [1 ]
Parikh, Kathan [1 ]
El-Ghazali, Ayea [1 ]
Woods, Mae [1 ]
Sauer, Tim [1 ]
Zhang, Huimin [1 ]
Mehta, Birju [1 ]
Torrano, Vicky [1 ]
Grilley, Bambi [1 ]
Heslop, Helen [1 ,3 ,4 ]
Rooney, Cliona [1 ]
机构：
[1] Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA
[2] Baylor Coll Med, Grad Sch Biomed Sci, Houston, TX 77030 USA
[3] Houston Methodist, Houston, TX USA
[4] Texas Childrens Hosp, Houston, TX 77030 USA
来源：
MOLECULAR THERAPY | 2021年 / 29卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
141
引用
收藏
页码：71 / 72
页数：2
相关论文
共 50 条
  • [21] Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes (CTL) for the treatment of patients with EBV-positive relapsed nasopharingeal carcinoma
    Comoli, P
    Pedrazzoli, P
    Nocera, A
    Labirio, M
    Del Galdo, F
    Basso, S
    Schiavo, R
    Tagliamacco, A
    Carminati, O
    De Palma, R
    Siena, S
    Locatelli, F
    Maccario, R
    BONE MARROW TRANSPLANTATION, 2002, 29 : S191 - S191
  • [22] Infusion of autologous Epstein-Barr Virus (EBV)-specific cytotoxic T cells can treat chronic active EBV infection.
    Savoldo, B
    Huls, HM
    Liu, ZS
    Volk, HD
    Reinke, P
    Sabat, R
    Babel, N
    Jones, JF
    Gee, AP
    Brenner, MK
    Heslop, HE
    Rooney, CM
    BLOOD, 2001, 98 (11) : 502A - 502A
  • [23] Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes for the treatment of patients with EBV-positiye relapsed Hodgkin's disease
    Roskrow, MA
    Suzuki, N
    Gan, YJ
    Sixbey, JW
    Ng, CYC
    Kimbrough, S
    Hudson, M
    Brenner, MK
    Heslop, HE
    Rooney, CM
    BLOOD, 1998, 91 (08) : 2925 - 2934
  • [24] Opportunities to Target the Life Cycle of Epstein-Barr Virus (EBV) in EBV-Associated Lymphoproliferative Disorders
    Dugan, James P.
    Coleman, Carrie B.
    Haverkos, Bradley
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [25] Clonal propagation of Epstein-Barr virus (EBV) recombinants in EBV-negative Akata cells
    Shimizu, N
    Yoshiyama, H
    Takada, K
    JOURNAL OF VIROLOGY, 1996, 70 (10) : 7260 - 7263
  • [26] Kinetics of Epstein-Barr Virus (EBV) Neutralizing and Virus-Specific Antibodies after Primary Infection with EBV
    Bu, Wei
    Hayes, Gregory M.
    Liu, Hui
    Gemmell, Lorraine
    Schmeling, David O.
    Radecki, Pierce
    Aguilar, Fiona
    Burbelo, Peter D.
    Woo, Jennifer
    Balfour, Henry H., Jr.
    Cohen, Jeffrey I.
    CLINICAL AND VACCINE IMMUNOLOGY, 2016, 23 (04) : 363 - 369
  • [27] Epstein-Barr Virus (EBV)-specific T cells as a diagnostic marker for the individual EBV-specific immune response after pediatric kidney transplantation
    Ahlenstiel-Grunow, Thurid
    Pape, Lars
    PEDIATRIC TRANSPLANTATION, 2019, 23
  • [28] Epstein-Barr virus (EBV)-associated miRNAs are important for the maintenance of EBV transformed B cells
    Sarah Linnstaedt
    Eva Gottwein
    Micah Luftig
    Bryan Cullen
    Infectious Agents and Cancer, 5 (Suppl 1)
  • [29] Biological aspects of Epstein-Barr virus (EBV)-infected lymphocytes in chronic active EBV infection and associated malignancies
    Kanegane, H
    Nomura, K
    Miyawaki, T
    Tosato, G
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2002, 44 (03) : 239 - 249
  • [30] GENERATION OF EPSTEIN-BARR VIRUS ANTIGEN-SPECIFIC SUPPRESSOR T-CELLS INVITRO
    SUNDAR, SK
    MENEZES, J
    INTERNATIONAL JOURNAL OF CANCER, 1985, 35 (03) : 351 - 357
12345